View on market: Stay Cautious, be with quality business:
Asian equities fell on Friday, following declines on Wall Street as the fastest inflation in 40 years drove U.S. bond yields higher and raised expectations for steeper interest-rate hikes. Stocks in Japan and Australia slid, U.S. futures were little changed after a selloff on Thursday. The Singapore-traded SGX Nifty, an early barometer of India’s benchmark Nifty 50 index, fell 0.58% to 16,474.5 points as of 7:05 am. Oil pared overnight losses but is still more than 7% lower on the week. The 10-year U.S. Treasury yield was steady after touching above 2%, while the 30-year rate reached the highest since May 2021. The European Central Bank unexpectedly accelerated its wind-down of monetary stimulus, signaling it’s more concerned about record inflation than weaker economic growth. Bitcoin hovered around $38,700.
Economic Calendar:
- INR: Bank Loan Growth on 14th March 2022.
- INR: WPI Inflation on 14th March 2022.
- USD: Federal Budget Balance on 11th March, 2022.
- USD: US Rig Count on 11th March, 2022.
Brokerage Radar:
JP MORGAN ON COLGATE: Neutral, TP Rs 1580 Ms. Prabha Narasimhan to take over as MD & CEO An external hire for the CEO position is a bit of an unanticipated move Key priorities – accelerating rev growth in oral care biz & strengthening non-oral care portfolio.
INVESTEC ON EXIDE: Buy, TP cut to Rs 220 Entered into a technical collaboration agreement with SVOLT Energy for lithium-ion cell manufacturing in India With technical tie-up, a strong b/s & deep relationships with OEMs, foray in EV batteries should be seamless.
JEFFERIES ON THERMAX: Buy, TP Rs 2575 Believe biz model change points to strong earnings recovery although thermal captive power is unlikely to grow & is being under-appreciated 38% EPS CAGR in FY21-25E & 19% ROE vs 8% should drive upside from current levels.
International Markets:
U.S & Europe:
| Particulars | 10th Mar | Chg | Chg(%) |
| Nasdaq | 13,129.96 | -125.59 | -0.95 |
| Dow | 33174.07 | 112.18 | -0.34 |
| FTSE | 7,099.09 | -91.63 | -1.27 |
| CAC | 6,207.20 | -180.63 | -2.83 |
| DAX | 13,442.10 | -405.83 | -2.93 |
| Dow Fut.* | 33066.1 | -108.5 | -0.32 |
*As per 11thMar.
Asian markets:
| Particulars | 11th Mar | Chg. | Chg(%) |
| SGX Nifty | 16,514.50 | -55.5 | -0.33 |
| Nikkei | 25,064.74 | -625.66 | -2.44 |
| Straits Times | 3,234.83 | -5.9 | -0.18 |
| Hang Seng | 20,226.83 | -663.43 | -3.18 |
| Shanghai | 3,249.41 | -46.68 | -1.42 |
ADR Watch:
| Particulars | 10th Mar | Chg. | Chg.(%) |
| Dr Reddy | 50.56 | -0.91 | -1.77 |
| HDFC Bank | 57.33 | -1.77 | -2.99 |
| ICICI Bank | 17.66 | -0.24 | -1.34 |
| Infosys | 23.84 | -0.06 | -0.25 |
| Tata Motor | 26.12 | -0.52 | -1.95 |
| Wipro | 7.57 | -0.03 | -0.39 |
Commodities & Currency:
| Particulars | Current Price | Chg(%) |
| USD/INR | 76.31 | -0.45 |
| Brent | 109.22 | -0.17 |
| Gold | 1997.10 | -0.15 |
| Silver | 26.115 | -0.50 |
FIIs & DII:
| Particulars | 10th Mar | 9th Mar |
| FIIs | -1981.15 | -4818.71 |
| DIIs | 945.71 | 3275.94 |
News Update:
Mahindra & Mahindra Financial Services: Mahindra Finance USA, a joint venture with Rabobank Group, has been extended.
Bayer CropScience: The company will sell its Environmental Science Professional business to Cinven for $2.6 billion.
Supreme Petrochem: The company has approved Phase II expansion of its expandable polystyrene plant at Nagothane, Maharashtra, by 30,000 million tonnes per annum. It also approved setting of second line of extruded polystyrene board with capacity of 100,000 MTA and increasing the masterbatch and compounds capacity by 50,000 MTA.
Sun Pharma: Cipher extends distribution pact with the company.
Lupin: Lupin Diagnostics has launched its first reference laboratory in East India in Kolkata.
NMDC: The company has executed the share purchase agreement for sale of its entire equity holding of 10.1% in Neelachal Ispat Nigam.
Jindal Steel and Power: Declared interim dividend of Rs 1 per share.
Kirloskar Ferrous: The company has acquired 51.25% stake in ISMT. Rahul Kirloskar will take over as chairman, Ravindranath Gumaste as vice chairman and Nishikant Balakrishna Ektare as MD. UCO Bank: The lender has acquired 3% equity stake in India Debt Resolution Company for a consideration of Rs 1.5 crore.
Zydus Lifesciences: Gets final U.S. FDA approval for Nitroglycerin Sublingual Tablets.
Wipro: The company has announced a long-term partnership with Pandorum Technologies for development of technologies that shorten time-to-market and maximise patient outcome during R&D and clinical trials of regenerative medicine.
Indraprastha Gas: Received a letter of intent from the Petroleum and Natural Gas Regulatory Board for for development of CGD network in Banda, Chitrakoot and Mahoba in Uttar Pradesh.
Tata Steel: The company, along with Tata Steel Long Products, has executed the share sale agreement with MMTC, NMDC, MECON, BHEL, Odisha Mining Corporation, President of India, Government of Odisha, Neelachal Ispat Nigam for acquisition of 93.71% equity shares in NINL.
Infosys: Announced a multi-year transformational collaboration with International Tennis Hall of Fame, making the company ITHF’s official digital innovation partner and title sponsor of the annual ATP Tour tournament — the Infosys Hall of Fame Open.
Source: Moneycontrol, Livemint,, Bloomberg, Investing
News Update:
Jindal Stainless (Hisar): Became the first company producing coils, sheets and plates in the country to be certified with AS 9100D Certification—a quality management system for aviation, space and defence organisations. It also enables JSHL to get listed in the Online Aerospace Supplier Information System database, which showcases the company offerings to aerospace manufacturers.
Bharti Airtel: The telecom firm has agreed to aquire a little over 9% equity stake in Avaada CleanTN Project, a special purpose vehicle for owning and operating the captive power plant. The deal value is pegged at Rs 7.88 crore.
Future Lifestyle: The company has received termination notices on sub-leased properties from Reliance entities. Notices pertain to 34 Central stores and 78 Brand Factory stores that contribute 55-65% of retail revenue operations.
NTPC: Unit-3 of the 660 MW Nabinagar Power Generating Co. Ltd. has completed trial and operation and has been consequently included in the installed capacity of NTPC Group. The total installed capacity of Nabinagar Power and NTPC Group now stands at 1,980 MW and 68,567.18 MW, respectively.
Indian Bank: The lender has appointed Aditya Gaiha as director (RBI nominee) on its board of directors, replacing SK Panigrahy with immediate effect.
Vakrangee: The Reserve Bank of India has extended the validity of authorisation issued to the company to setup, own, and operate white-label ATMs in India till March 31, 2023.
Tata Power: Resurgent Power, in which the Tata Group firm holds 26% stake, has emerged as the successful bidder for South East UP Power Transmission Co.
Zydus Lifesciences: Gets final U.S. FDA approval for Nitroglycerin Sublingual Tablet
J.Kumar Infraprojects: The company has bagged work order from Pune Municipal Corporation for development of Mula Mutha River from Bund Garden Bridge to Mundhwa worth Rs 604.75 crore. The company also received a letter of acceptance from Delhi Metro Rail Corporation worth 1,426 crore.
Restaurant Brands Asia: The company has completed acquisition of 87.75% stake in Burger King Indonesia (PT Sari Burger Indonesia).
Uttam Sugar: The company has redeemed 1,00,000, 6.50% non-cumulative redeemable preference shares of Rs 100 each.
Source: Moneycontrol, Livemint,, Bloomberg, Investing
Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014
Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL